AME

AME Company for Medical Supplies

9527StocksTadawulIndustrials

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (SAR)

	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021	2020Dec 31, 2020
Operating Summary
Revenue	248.35M	220.01M	193.17M	151.39M	121.60M
Cost of Revenue	146.19M	124.57M	102.89M	81.84M	66.32M
Gross Profit	102.16M	95.45M	90.28M	69.54M	55.28M
SG&A	59.19M	56.56M	52.68M	40.38M	29.09M
Operating Expenses	52.83M	58.61M	60.55M	45.11M	32.64M
Operating Income	49.33M	36.84M	29.73M	24.44M	22.64M
Interest Expense	-171.12K	-206.62K	-103.89K	-168.66K	-71.99K
Pretax Income	50.04M	37.58M	30.03M	24.21M	22.57M
Income Tax	4.64M	4.07M	3.35M	2.99M	1.50M
Net Income	45.40M	33.52M	26.68M	21.22M	21.07M
EBITDA	50.05M	37.26M	30.01M	24.56M	22.76M
EBIT	49.33M	36.84M	29.73M	24.44M	22.64M
EPS (Basic)	6.49	4.79	3.81	3.05	3.67
EPS (Diluted)	6.49	4.79	3.81	3.05	3.67
DPS	2.00	2.00	2.00	1.75	—
Margins & Efficiency
Gross Margin %	+41.1%	+43.4%	+46.7%	+45.9%	+45.5%
EBITDA Margin %	+20.2%	+16.9%	+15.5%	+16.2%	+18.7%
Net Margin %	+18.3%	+15.2%	+13.8%	+14.0%	+17.3%
Revenue & Income
Revenue	248.35M	220.01M	193.17M	151.39M	121.60M
Revenue Growth (YoY)	+12.9%	+13.9%	+27.6%	+24.5%	+35.2%
Currency Exchange Gain (Loss)	886.92K	951.33K	406.85K	-56.98K	—
Expenses & Provisions
Cost of Revenue	146.19M	124.57M	102.89M	81.84M	66.32M
Selling, General & Admin	59.19M	56.56M	52.68M	40.38M	29.09M
Operating Expenses	52.83M	58.61M	60.55M	45.11M	32.64M
Other Operating Expenses	-4.63M	-4.11M	—	4.45M	—
Interest Expense	-171.12K	-206.62K	-103.89K	-168.66K	-71.99K
D&A For EBITDA	717.71K	417.58K	279.63K	122.40K	115.82K
Profitability & Returns
Gross Profit	102.16M	95.45M	90.28M	69.54M	55.28M
Gross Margin	+41.1%	+43.4%	+46.7%	+45.9%	+45.5%
EBIT	49.33M	36.84M	29.73M	24.44M	22.64M
EBIT Margin	+19.9%	+16.7%	+15.4%	+16.1%	+18.6%
EBITDA	50.05M	37.26M	30.01M	24.56M	22.76M
EBITDA Margin	+20.2%	+16.9%	+15.5%	+16.2%	+18.7%
Pretax Income	50.04M	37.58M	30.03M	24.21M	22.57M
Operating Income	49.33M	36.84M	29.73M	24.44M	22.64M
Operating Margin	+19.9%	+16.7%	+15.4%	+16.1%	+18.6%
Profit Margin	+18.3%	+15.2%	+13.8%	+14.0%	+17.3%
Net Income	45.40M	33.52M	26.68M	21.22M	21.07M
Net Income to Common	45.40M	33.52M	26.68M	21.22M	21.07M
Net Income Growth	+35.5%	+25.6%	+25.7%	+0.7%	+42.3%
Income Tax Expense	4.64M	4.07M	3.35M	2.99M	1.50M
Effective Tax Rate	+9.3%	+10.8%	+11.2%	+12.3%	+6.6%
Per Share & Capital
EPS (Basic)	6.49	4.79	3.81	3.05	3.67
EPS (Diluted)	6.49	4.79	3.81	3.05	3.67
EPS Growth	+35.5%	+25.6%	+24.9%	-16.9%	-87.6%
Dividend Per Share	2.00	2.00	2.00	1.75	—
Shares Change (YoY)	—	—	0.01	0.21	10.48
Shares Outstanding (Basic)	7.00M	7.00M	7.00M	6.96M	5.74M
Shares Outstanding (Diluted)	7.00M	7.00M	7.00M	6.96M	5.74M
Dividend Growth	—	—	+14.3%	—	—
Free Cash Flow	-3.90M	34.72M	7.56M	19.93M	2.45M
Free Cash Flow Margin	-1.6%	+15.8%	+3.9%	+13.2%	+2.0%
Free Cash Flow Per Share	-0.56	4.96	1.08	2.87	0.43
Payout Ratio	+30.8%	+41.7%	+45.9%	+7.5%	—

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (SAR)

	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021	2020Dec 31, 2020
Operating Summary
Revenue	248.35M	220.01M	193.17M	151.39M	121.60M
Cost of Revenue	146.19M	124.57M	102.89M	81.84M	66.32M
Gross Profit	102.16M	95.45M	90.28M	69.54M	55.28M
SG&A	59.19M	56.56M	52.68M	40.38M	29.09M
Operating Expenses	52.83M	58.61M	60.55M	45.11M	32.64M
Operating Income	49.33M	36.84M	29.73M	24.44M	22.64M
Interest Expense	-171.12K	-206.62K	-103.89K	-168.66K	-71.99K
Pretax Income	50.04M	37.58M	30.03M	24.21M	22.57M
Income Tax	4.64M	4.07M	3.35M	2.99M	1.50M
Net Income	45.40M	33.52M	26.68M	21.22M	21.07M
EBITDA	50.05M	37.26M	30.01M	24.56M	22.76M
EBIT	49.33M	36.84M	29.73M	24.44M	22.64M
EPS (Basic)	6.49	4.79	3.81	3.05	3.67
EPS (Diluted)	6.49	4.79	3.81	3.05	3.67
DPS	2.00	2.00	2.00	1.75	—
Margins & Efficiency
Gross Margin %	+41.1%	+43.4%	+46.7%	+45.9%	+45.5%
EBITDA Margin %	+20.2%	+16.9%	+15.5%	+16.2%	+18.7%
Net Margin %	+18.3%	+15.2%	+13.8%	+14.0%	+17.3%
Revenue & Income
Revenue	248.35M	220.01M	193.17M	151.39M	121.60M
Revenue Growth (YoY)	+12.9%	+13.9%	+27.6%	+24.5%	+35.2%
Currency Exchange Gain (Loss)	886.92K	951.33K	406.85K	-56.98K	—
Expenses & Provisions
Cost of Revenue	146.19M	124.57M	102.89M	81.84M	66.32M
Selling, General & Admin	59.19M	56.56M	52.68M	40.38M	29.09M
Operating Expenses	52.83M	58.61M	60.55M	45.11M	32.64M
Other Operating Expenses	-4.63M	-4.11M	—	4.45M	—
Interest Expense	-171.12K	-206.62K	-103.89K	-168.66K	-71.99K
D&A For EBITDA	717.71K	417.58K	279.63K	122.40K	115.82K
Profitability & Returns
Gross Profit	102.16M	95.45M	90.28M	69.54M	55.28M
Gross Margin	+41.1%	+43.4%	+46.7%	+45.9%	+45.5%
EBIT	49.33M	36.84M	29.73M	24.44M	22.64M
EBIT Margin	+19.9%	+16.7%	+15.4%	+16.1%	+18.6%
EBITDA	50.05M	37.26M	30.01M	24.56M	22.76M
EBITDA Margin	+20.2%	+16.9%	+15.5%	+16.2%	+18.7%
Pretax Income	50.04M	37.58M	30.03M	24.21M	22.57M
Operating Income	49.33M	36.84M	29.73M	24.44M	22.64M
Operating Margin	+19.9%	+16.7%	+15.4%	+16.1%	+18.6%
Profit Margin	+18.3%	+15.2%	+13.8%	+14.0%	+17.3%
Net Income	45.40M	33.52M	26.68M	21.22M	21.07M
Net Income to Common	45.40M	33.52M	26.68M	21.22M	21.07M
Net Income Growth	+35.5%	+25.6%	+25.7%	+0.7%	+42.3%
Income Tax Expense	4.64M	4.07M	3.35M	2.99M	1.50M
Effective Tax Rate	+9.3%	+10.8%	+11.2%	+12.3%	+6.6%
Per Share & Capital
EPS (Basic)	6.49	4.79	3.81	3.05	3.67
EPS (Diluted)	6.49	4.79	3.81	3.05	3.67
EPS Growth	+35.5%	+25.6%	+24.9%	-16.9%	-87.6%
Dividend Per Share	2.00	2.00	2.00	1.75	—
Shares Change (YoY)	—	—	0.01	0.21	10.48
Shares Outstanding (Basic)	7.00M	7.00M	7.00M	6.96M	5.74M
Shares Outstanding (Diluted)	7.00M	7.00M	7.00M	6.96M	5.74M
Dividend Growth	—	—	+14.3%	—	—
Free Cash Flow	-3.90M	34.72M	7.56M	19.93M	2.45M
Free Cash Flow Margin	-1.6%	+15.8%	+3.9%	+13.2%	+2.0%
Free Cash Flow Per Share	-0.56	4.96	1.08	2.87	0.43
Payout Ratio	+30.8%	+41.7%	+45.9%	+7.5%	—